EMEA-001159-PIP02-12
Key facts
| Active substance |
misoprostol
|
| Therapeutic area |
Other
|
| Decision number |
P/0163/2012
|
| PIP number |
EMEA-001159-PIP02-12
|
| Pharmaceutical form(s) |
Vaginal delivery system
|
| Condition(s) / indication(s) |
Induction of labour
|
| Route(s) of administration |
Vaginal use
|
| Contact for public enquiries |
Ferring pharmaceuticals A/S
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
| Compliance procedure number |
EMEA-C-001159-PIP02-12
|
| Compliance opinion date |
11/10/2012
|
| Compliance outcome |
positive
|